Self-detected Melanomas are Thicker Regardless of Patient’s Complexity: A Retrospective Analysis
Keywords:cancer early detection, malignant melanoma, physical examination
Abstract missing (Short communication)
Olsen CM, Pandeya N, Thompson BS, Dusingize JC, Green AC, Neale RE, et al. Physician skin checks before the diagnosis of melanoma correlate with tumor characteristics. J Invest Dermatol 2018; 138: 2288-2291
The Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 9th edn. [accessed 2022 Nov18]. Available from: https://www.racgp.org.au/download/Documents/Guidelines/Redbook9/17048-Red-Book-9th-Edition.pdf.
Robinson JK, Wayne JD, Martini MC, Hultgren BA, Mallett KA, Turrisi R. Early detection of new melanomas by patients with melanoma and their partners using a structured skin self-examination skills training intervention: a randomized clinical trial. JAMA Dermatol 2016; 152: 979-985
Paiva ML, Weinstock MA. Melanoma overdiagnosis is not the key problem. JAMA Dermatol 2022; 158: 1082-1083
Bucchi L, Mancini S, Zamagni F, Crocetti E, Dal Maso L, Ferretti S et al. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: trends and correlations. J Eur Acad Dermatol Venereol 2023; 37: 293-302.
Avilés-Izquierdo JA, Molina-López I, Rodríguez-Lomba E, Marquez-Rodas I, Suarez-Fernandez R, Lazaro-Ochaita P. Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma. J Am Acad Dermatol 2016; 75: 967-974.
Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C, et al. Self-detected cutaneous melanomas in Italian patients. Clin Exp Dermatol 2004; 29: 593-596.
Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner MH. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007; 156: 938-944.
Pagliarello C, Magi S, Mazzoni L, Stanganelli I. Proportion of thick versus thin melanomas as a benchmarking tool. J Clin Med 2021; 10: 5545.
Long GV, Luke JJ, Khattak MA, de la Cruz Merino L, Del Vecchio M, Rutkowski P, et al. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial. Lancet Oncol 2022; 23: 1378-1388.
How to Cite
Copyright (c) 2023 Calogero Pagliarello, Carlo Renè Girardelli
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.